Literature DB >> 11397851

Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development.

C K Welt1, Z A Smith, D K Pauler, J E Hall.   

Abstract

Inhibin B and inhibin A exhibit unique patterns of secretion across the follicular phase of the menstrual cycle. To test the hypothesis that the distinct patterns of inhibin B and inhibin A secretion result from differential regulation by LH and FSH, a series of controlled experiments was designed to dissect the specific effects of LH and FSH at distinct stages of follicle development. After GnRH agonist desensitization, women with small antral follicles were treated with recombinant human LH (rhLH), rhFSH, or rhFSH and estradiol (E(2)). rhLH or rhFSH was also administered when follicles reached the preovulatory stage in gonadotropin-stimulated or spontaneous cycles. At the small antral stage of development, rhFSH, but not rhLH, administration increased inhibin B (17.4 +/- 4.6 to 321.0 +/- 97.0 pg/mL; P < 0.05), inhibin A (0.6 +/- 0.1 to 2.6 +/- 0.6 IU/mL; P < 0.05), and E(2) [15.8 +/- 3.6 to 95.3 +/- 26.9 pg/mL (58.0 +/- 13.2 to 349.8 +/- 98.7 pmol/L); P < 0.05]. The inhibin B increase preceded inhibin A by 48 h. Addition of E(2) to FSH resulted in a greater increase in inhibin B (23.2 +/- 6.4 to 865.2 +/- 294.5 pg/mL; P < 0.05) than FSH alone (P < 0.05). At the preovulatory stage, rhLH administration increased inhibin A (15.9 +/- 10.3 to 21.5 +/- 13.7 IU/mL; P < 0.05) and E(2) [669.4 +/- 285.5 to 943.6 +/- 388.1 pg/mL (2457.4 +/- 1048.1 to 3464.0 +/- 1424.7 pmol/L); P < 0.05], but not inhibin B, as did rhFSH administration in spontaneous cycles [E(2): 226.4 +/- 102.7 to 264.7 +/- 121.0 pg/mL (831.1 +/- 377.0 to 971.7 +/- 444.2 pmol/L); P < 0.05; inhibin A: 2.6 +/- 1.3 to 3.7 +/- 1.9 IU/mL; P < 0.05; and inhibin B: 76.3 +/- 32.2 to 77.6 +/- 32.8 pg/mL; P = NS]. These findings suggest that increases in both FSH and E(2) in the early follicular phase result in increased inhibin B secretion at early stages of follicle development, whereas the selective LH rise in the late follicular phase favors inhibin A secretion from more mature follicles. Thus, both differential secretion of LH and FSH and the stage of follicle development determine the patterns of inhibin A and inhibin B secretion in the normal menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11397851     DOI: 10.1210/jcem.86.6.7597

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Plasma concentrations of ir-inhibin, inhibin A, inhibin pro-alphaC, FSH, and estradiol-17beta during estrous cycle in mares and their relationship with follicular growth.

Authors:  Mohamed S Medan; Yasuo Nambo; Natsuko Nagamine; Hiromi Shinbo; Gen Watanabe; Nigel Groome; Kazuyoshi Taya
Journal:  Endocrine       Date:  2004-10       Impact factor: 3.633

Review 2.  Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation.

Authors:  Jerilynn C Prior
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

Review 3.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

4.  Expression of inhibin-activin subunits, follistatin and smads in granulosa-luteal cells collected at oocyte retrieval.

Authors:  Shiuh Young Chang; Hong-Yo Kang; Kuo-Chung Lan; Chang-Yi Hseh; Fu-Jen Huang; Ko-En Huang
Journal:  J Assist Reprod Genet       Date:  2006-10-12       Impact factor: 3.412

Review 5.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

6.  Characterization of functionally typical and atypical types of polycystic ovary syndrome.

Authors:  Jennifer Hirshfeld-Cytron; Randall B Barnes; David A Ehrmann; Anthony Caruso; Monica M Mortensen; Robert L Rosenfield
Journal:  J Clin Endocrinol Metab       Date:  2009-02-24       Impact factor: 5.958

7.  Decreased inhibin B responses following recombinant human chorionic gonadotropin administration in normal women and women with polycystic ovary syndrome.

Authors:  Rana F Shayya; Marcus A Rosencrantz; Sandy S Chuan; Heidi Cook-Andersen; William E Roudebush; H Irene Su; Shunichi Shimasaki; R Jeffrey Chang
Journal:  Fertil Steril       Date:  2013-11-01       Impact factor: 7.329

8.  Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone.

Authors:  Konstantinos Dafopoulos; Christos Venetis; Christina I Messini; Spyros Pournaras; George Anifandis; Antonios Garas; Ioannis E Messinis
Journal:  Reprod Biol Endocrinol       Date:  2011-04-29       Impact factor: 5.211

9.  RNAi-mediated knockdown of INHBB increases apoptosis and inhibits steroidogenesis in mouse granulosa cells.

Authors:  Mohamed M'baye; Guohua Hua; Hamid Ali Khan; Liguo Yang
Journal:  J Reprod Dev       Date:  2015-06-09       Impact factor: 2.214

10.  Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.

Authors:  Aylin Yetim; Çağcıl Yetim; Firdevs Baş; Oğuz Bülent Erol; Gülnaz Çığ; Ahmet Uçar; Feyza Darendeliler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.